JH DeVries, FJ Snoek, PJ Kostense, N Masurel, RJ … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—As the drop-out rate after crossover was high (17 of 79 patients [22%]), we analyzed
the trial as a parallel clinical trial, using data of the first half of the crossover phase only. At 16
weeks, mean HbA 1c was 0.84% (95% CI −1.31 to −0.36) lower in the continuous ... Cited by 77 - Related articles - BL Direct - All 6 versions
E Tsui, A Barnie, S Ross, R Parkes, B Zinman - Diabetes Care, 2001 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—This clinical trial enrolled 27 patients with type 1
diabetes. They were randomly assigned to CSII (n = 13) or MDI (n = 14) treatment regimens.
Glycemic control (HbA 1c level) was the primary outcome and was measured monthly for ... Cited by 80 - Related articles - BL Direct - All 10 versions
- ►diabetesjournals.org [PDF] H Hanaire-Broutin, V Melki, S Bessieres-Lacombe, … - Diabetes Care, 2000 - Am Diabetes Assoc According to the results of the Diabetes Control and Complications Trial (DCCT) (1), intensive
diabetes man- agement should be proposed for most type 1 diabetic patients to prevent
long-term com- plications. However, the ideal insulin regi- men should simultaneously ... Cited by 100 - Related articles - BL Direct - All 7 versions
R Linkeschova, M Raoul, U Bott, M Berger, M … - Diabetic …, 2002 - interscience.wiley.com MethodsOne hundred and three patients (58 women) started CSII between October 1995 and
April 1999 in our department. The indication for CSII was optimization of metabolic control and
improvement of flexibility of life style (OF group) in 60 patients (58%), and prevention of ... Cited by 85 - Related articles - BL Direct - All 4 versions
BW Bode, P Strange - Diabetes Care, 2001 - Am Diabetes Assoc OBJECTIVE— The purpose of this study was to compare the efficacy, safety, and pump compatibility
of insulin aspart (a rapid-acting insulin analog) and buffered regular human insulin in patients
with type 1 diabetes undergoing continuous subcutaneous insulin infusion (CSII) therapy. Cited by 83 - Related articles - BL Direct - All 13 versions
D Bruttomesso, A Pianta, D Crazzolara, E … - Diabetic …, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 49 - Related articles - BL Direct - All 5 versions
[CITATION] Tri-Continental Insulin Aspart Study Group. A randomized trial of insulin aspart with …
- ►bentham.org [PDF] JH DeVries - Current Diabetes Reviews, 2005 - ingentaconnect.com Abstract: Insulin pump therapy enjoys a steadily growing number of users and is associated with
an approximately 0.5% lower A1c as compared to flexible insulin injection therapy in type 1 diabetes
patients. An important question is whether superiority of insulin pump therapy persists in ... Cited by 1 - Related articles - BL Direct - All 5 versions
JH DeVries, A Lindholm, JL Jacobsen, RJ … - Diabetic …, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 20 - Related articles - BL Direct - All 4 versions
